Last reviewed · How we verify
Yasmin
At a glance
| Generic name | Yasmin |
|---|---|
| Also known as | drospirenone and ethinyl estradiol tablets, OCP, combined oral contraceptive |
| Sponsor | Inonu University |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Boxed warnings
- WARNING: CIGARETTE SMOKING AND SERIOUS CARDIOVASCULAR EVENTS Cigarette smoking increases the risk of serious cardiovascular events from combination oral contraceptives (COC) use. This risk increases with age, particularly in women over 35 years of age, and with the number of cigarettes smoked. For this reason, COCs should not be used by women who are over 35 years of age and smoke [see Contraindications ( 4 )] . WARNING: CIGARETTE SMOKING AND SERIOUS CARDIOVASCULAR EVENTS See full prescribing in
Common side effects
- Premenstrual syndrome
- Headache/migraine
- Breast pain/tenderness/discomfort
- Nausea/vomiting
- Abdominal pain/tenderness/discomfort
- Mood changes
Serious adverse events
- Pulmonary embolism
- Venous and arterial thromboembolic events
- Deep vein thrombosis
- Stroke
- Myocardial infarction
- Depression
- Intracranial venous sinus thrombosis
- Uterine leiomyoma
- Toxic skin eruption
- Retinal vein occlusion
Key clinical trials
- Effects of VX-407 on the Pharmacokinetics of Oral Contraceptives in Healthy Participants (PHASE1)
- A Drug-drug Interaction Study to Evaluate the Effects of Pelabresib on the Pharmacokinetics of Repaglinide, Midazolam, and Combined Oral Contraceptive in Patients With Advanced Malignancies (PHASE1)
- Effect of Drospirenone-Ethinyl Estradiol (20microgram vs 30 Microgram) on Free Androgen Index in PCOS (NA)
- Continuous Versus Cyclical OCP Use in PCOS (PHASE4)
- A Drug-Drug Interaction Study Between HS-10374 Tablets and Drospirenone and Ethinyl Estradiol Tablets(Yasmin®) (PHASE1)
- Evaluation of the Effect of Suzetrigine (SUZ) on the Pharmacokinetics of Oral Contraceptives in Healthy Female Participants (PHASE1)
- A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood (PHASE1)
- Can Drospirenone be Used to Prevent LH Surge in Controlled Ovarian Stimulation in PCOS?! (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |